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Analysis of pediatric deaths associated with pandemic A H1N1 influenza
shows that fatal outcome is more likely in young children, under the age of
5. Neonates, because of the immaturity of their immune system, could
represent a high-risk group for severe disease and fatal outcome. We present
a group of five neonates with confirmed novel influenza A H1N1 infection.
This report indicates that the full spectrum of influenza A H1N1 infection
ranging from mild febrile illness with spontaneous recovery to severe disease
with fatal outcome may be expected even in neonates.
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Introduction
Due to the rapid spread of novel swine-origin influenza A H1N1
virus, the World Health Organization (WHO) in June 2009 declared
the pandemic to be one at the highest level.1 Analysis of pediatric
deaths associated with pandemic A H1N1 influenza shows that fatal
outcome is more likely in children under the age of 5.2 Neonates,
because of the immaturity of their immune system, could represent
a high-risk group.3 However, reports on infection with H1N1
influenza in neonates are very scarce.
In this paper, we present a group of five neonates with
confirmed influenza H1N1 infection that were treated in our
hospital from October 2009 until February 2010. According to our
best knowledge, this is a unique report focusing exclusively on
newborn infants with a broad spectrum of influenza H1N1 disease
ranging from non-specific signs of infection or mild respiratory




A female, term infant was born by cesarean section due to fetal
distress. She received bag and mask ventilation in the delivery
room and suffered from recurrent apnea thereafter, requiring
mechanical ventilation. After several unsuccessful weaning
attempts, the infant was transferred to our hospital for further
treatment on the 24th day of life. Immediate flexible bronchoscopy
revealed the presence of laryngomalacia, bilateral vocal cord
paresis and hypotonia of hypopharyngeal muscles. After 24 h, the
newborn became febrile to 38.3 1C, tachycardic, tachypneic and
hypoxemic. Because of the possible intrahospital infection,
antibiotic therapy (vancomycin and meropenem) was commenced.
But, after 48 h cultures of blood, urine and tracheal aspirate were
sterile and respiratory syncytial virus antigen was not detected in
nasopharyngeal aspirate, so a nasopharyngeal swab specimen for
pandemic influenza H1N1 testing was taken. Infection was
confirmed by real-time reverse transcription-PCR of the
nasopharyngeal swab specimen. Therapy with oseltamivir
(2 mg kg1 per dose) was started 72 h after deterioration. On the
following days, the baby was still febrile and hypoxemic, with
progression of respiratory failure and chest X-ray consistent with
development of acute respiratory distress syndrome. In spite of
treatment attempts with porcine surfactant, inhaled NO, as well as
hemodiafiltration, clinical deterioration progressed, resulting in the
patient’s death after 3 weeks.
An autopsy revealed diffuse changes in the lung parenchyme
with signs of severe interstitial fibrosis, epithelial denudation and
squamous metaplasia of the muscular layer in bronchioles, as well
as diffuse alveolar damage with marked hyaline membrane
formation and bilateral acute bronchopneumonia.
Case 2–5
Another four newborns with infection caused by influenza A H1N1
virus were treated in our hospital from October 2009 until February
2010. Patient characteristics are summarized in Table 1. Two
infants were born in late preterm gestation. Three of them were
hospitalized because of fever and non-specific symptoms of
infection. Only patient 4 had mild respiratory symptoms.
Transmission occurred most probably by direct contact with family
members or caregivers. Laboratory findings, also presented in
Table 1, were consistent with viral infection. All newborns were
negative for respiratory syncytial virus infection, but
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influenza H1N1 testing by PCR were positive. Two newborns were
admitted in the evening and the results were available early
afternoon the next day. At that time both patients were afebrile with
improved general condition and therapy with oseltamivir was not
started. In the other two patients therapy was started within the first
24 h of hospitalization. The average stay in hospital was 5.5 days
(ranging from 4 to 7 days).
Discussion
Although outbreaks in neonatal intensive units have been described
during the influenza epidemic, influenza has been an uncommon
illness in newborns.4 Recent animal as well as human infant
studies suggest that failure to develop a cytotoxic T lymphocyte
response is a possible cause of the high rate of infant morbidity
and mortality caused by respiratory viruses.3,5
Among the 39 pediatric deaths associated with H1N1 novel
influenza infection in the United States, 67% had at least one high-
risk medical condition.2 Our first patient possibly belonged to the
high-risk group because of the congenital abnormality of the upper
respiratory tract as well as the prolonged mechanical ventilation.
Histological analysis on autopsy of the lungs in this patient was
consistent with pulmonary pathological findings observed in fatal
influenza H1N1 infection in adults.6 Approximately 30–40% of the
fatal cases with H1N1 novel influenza infection have a bacterial
coinfection, which was not confirmed in our patient, although
clinical, laboratory and autopsy findings suggested a bacterial
pulmonary superinfection.
Although transplacental infection during maternal viremia is
possible,7 the most frequent scenario would probably be the
transmission by direct contact with family members or caregivers.
History of influenza virus infection was positive in all our patients,
except for a first patient who had previously been hospitalized at
another medical institution. Nosocomial transmission of 2009
H1N1 influenza was already reported in three pediatric patients
from Argentina.8
In spite of the fact that oseltamivir is approved for treatment
and prophylaxis of influenza in children X1 year of age, only few
studies demonstrate its safety in children lesser than 1 year old.9
The favorable course of illness in neonates with appropriate
initiation of antiviral therapy has recently been reported.7 On the
other hand, the same outcome was noted in our two patients with
mild disease who did not receive therapy. In the patient with lethal
disease, therapy with oseltamivir was started later than the
preferred 48 h from disease presentation, when the greatest benefit
for reducing the risk of severe disease is expected.10
Although we presented a small group of patients, it seems that
even in neonates influenza A H1N1 is usually a self-limiting illness,
but can cause a severe disease with fatal outcome. Pre-existing
co-morbidity might represent a risk for severe disease in neonates
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non-specific symptoms or mild influenza A H1N1 disease who did
not receive antiviral therapy. According to our limited experience in
two previously healthy newborns with mild disease and favorable
course of influenza H1N1 infection without antiviral therapy,
use of oseltamivir as ‘off-label’ drug in this group of patients could
be questioned.
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